Advocacy surrounding the development of pharmaceuticals for animals
2026 · 3rd Quarter (July 1 - Sep 30)
ELANCO ANIMAL HEALTH
Filed by BROWNSTEIN HYATT FARBER SCHRECK, LLP.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 19, 2026
- Income
- $140,000.00
- Expenses
- Not reported
- Registrant
- BROWNSTEIN HYATT FARBER SCHRECK, LLP
- Client
- ELANCO ANIMAL HEALTH
- Filing UUID
- d392188e-e876-40d8-942b-3025737c7f87
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Advocacy surrounding tariff policy for animal pharmaceuticals.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.